| | |
| Summary |
| Please note: The McKinsey Quarterly has agreed to a special arrangement for CEOExpress members that allows member access to their articles. Articles must be clicked on directly through the links below to gain access to this group of articles.
|
The Search For Blockbuster Drugs
Drugmakers don't have to be the first company to deliver blockbuster drugs: follow-ons that improve the original are often just as profitable, and sometimes more so. Just making drugs more effective rarely adds value, but reducing their side effects or extending their applications to other ailments often does.
The take-away: Pharmaceutical companies that make massive investments to discover revolutionary blockbuster drugs would probably see better returns by enhancing existing compounds.
Articles provided by The McKinsey Quarterly
© 1992-2003 McKinsey & Company, Inc
|
|
|
